Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Discovery Grants Program - Individual

University of Toronto

$27,000.00

Targeting Ultrasound Therapy to the Spine

FY 2020-21

Summary
Ultrasound (US) can elicit a range of therapeutic effects on tissues, including stimulating cell proliferation, facilitating drug delivery and focally ablating tissue. Because US is non-ionizing and can be focused at depth in the body without damage to the intervening tissues, it is particularly well suited for targets in, or in close proximity to, sensitive structures, and has great potential for use in the spine. US-mediated drug, cell or gene delivery to the spinal cord could revolutionize the treatment of spinal cord injury and disease. Targeted to the intervertebral disc or facet joints, US could play an important role in the management of back pain. A major limitation to the clinical realization of these treatments is the need to focus the US through the complex bony structures of the posterior spinal elements. Bone is highly attenuating and aberrating to sound, and treating through bony structures is only possible through the use of US transducer arrays that can correct the beam distortions caused by the bone, and which operate within an optimal frequency range. In the brain this technology is in-hand and has been investigated clinically. However, the spinal geometry is more complex than the skull. Acoustic windows such as the interlaminar spaces will facilitate access to some targets. In other regions, non-normal incidence angles will reflect and refract the US, and the narrow spinal canal may give rise to standing waves. Thus, the development of extracorporeal US transducer arrays that are capable of focusing in the spinal setting is necessary to advance this technology. The overall goal of this research program is to use numerical simulations and bench-top measurements to test the hypothesis that extracorporeal ultrasound can be focused non-invasively to targets in the spinal cord and spinal column at therapeutically relevant exposures. The specific aims to achieve this are: 1. To develop acoustic simulation models of the human spine at cervical, thoracic and lumbar levels using computed tomography (CT)-derived geometry. 2. To experimentally validate the numerical models through comparison with acoustic and thermal measurements in cadaveric spine segments. 3. To use the validated models to assess the ability of ultrasound to safely target different structures in the spine. 4. To determine, through numerical optimization, the ultrasound transducer geometry that maximizes the treatment envelope. 5. To fabricate and characterize a prototype transducer for targeting the spine. This research will lay the groundwork for clinical-scale investigations in the spine using therapeutic US, and has immense potential to be a disruptive technology in this arena. By eliminating a major obstacle to clinical translation, establishing the technical feasibility of this approach will also encourage further research to identify new clinical applications in the spine.
Program
Discovery Grants Program - Individual
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
RGPIN-2016-06336
Name nom
O'Reilly, Meaghan
Department département
Medical Biophysics
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2020
Competition year année de concours
2016
Award amount
27000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1505
Committee name en
Physics
Committee name fr
Physique
Area of application code
518
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Medical equipment and apparatus
Area of application fr
Appareils et instruments médicaux
Research subject code
3114
Research subject group en
Physics
Research subject group fr
Physique
Research subject en
Biological and Medical Physics
Research subject fr
Physique biologique et médicale
Installment
inst:5-6
Partie
2
Nb partie
6
Application title
Targeting Ultrasound Therapy to the Spine
Keyword
NSERC
Application summary
Ultrasound (US) can elicit a range of therapeutic effects on tissues, including stimulating cell proliferation, facilitating drug delivery and focally ablating tissue. Because US is non-ionizing and can be focused at depth in the body without damage to the intervening tissues, it is particularly well suited for targets in, or in close proximity to, sensitive structures, and has great potential for use in the spine. US-mediated drug, cell or gene delivery to the spinal cord could revolutionize the treatment of spinal cord injury and disease. Targeted to the intervertebral disc or facet joints, US could play an important role in the management of back pain. A major limitation to the clinical realization of these treatments is the need to focus the US through the complex bony structures of the posterior spinal elements. Bone is highly attenuating and aberrating to sound, and treating through bony structures is only possible through the use of US transducer arrays that can correct the beam distortions caused by the bone, and which operate within an optimal frequency range. In the brain this technology is in-hand and has been investigated clinically. However, the spinal geometry is more complex than the skull. Acoustic windows such as the interlaminar spaces will facilitate access to some targets. In other regions, non-normal incidence angles will reflect and refract the US, and the narrow spinal canal may give rise to standing waves. Thus, the development of extracorporeal US transducer arrays that are capable of focusing in the spinal setting is necessary to advance this technology. The overall goal of this research program is to use numerical simulations and bench-top measurements to test the hypothesis that extracorporeal ultrasound can be focused non-invasively to targets in the spinal cord and spinal column at therapeutically relevant exposures. The specific aims to achieve this are: 1. To develop acoustic simulation models of the human spine at cervical, thoracic and lumbar levels using computed tomography (CT)-derived geometry. 2. To experimentally validate the numerical models through comparison with acoustic and thermal measurements in cadaveric spine segments. 3. To use the validated models to assess the ability of ultrasound to safely target different structures in the spine. 4. To determine, through numerical optimization, the ultrasound transducer geometry that maximizes the treatment envelope. 5. To fabricate and characterize a prototype transducer for targeting the spine. This research will lay the groundwork for clinical-scale investigations in the spine using therapeutic US, and has immense potential to be a disruptive technology in this arena. By eliminating a major obstacle to clinical translation, establishing the technical feasibility of this approach will also encourage further research to identify new clinical applications in the spine.